Athghin Biotechnology Inc entered the industry of Commercial Biotechnical Research in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact David Eveleth by calling (518) 694-8188 during business hours. You can also write to the business’ Single Location at 1 Discovery Drive, Rensselaer, New York NY 12144. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Athghin Biotechnology Inc |
Representative: | David Eveleth |
Place of Business: | 1 Discovery Drive, Rensselaer, NY 12144 |
Contact Number: | (518) 694-8188 |
Type of Service: | Commercial Biotechnical Research |
SIC Number: | 8731 |
NAICS Number: | 541711 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2012 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Athghin Biotechnology Inc is a company operating from Rensselaer, New York providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2012 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Athghin Biotechnology Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative David Eveleth at (518) 694-8188 for related queries, or to locate its Single Location using the coordinates 42.626395,-73.739677.
The Single Location can also be found at the street address 1 Discovery Drive in Rensselaer, New York 12144 and can be engaged online through the company website at , the company Twitter , and Facebook page .